01:23 PM, 25th Jul 2025
Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025 along with the Limited Review Report for the said period.